Efficacy and safety of methylphenidate and ginseng in cancer-related fatigue: a network meta-analysis of randomized controlled trials
Translational Cancer Research · 2023-04 · 12 (4) · 732-742
DOI: 10.21037/tcr-22-2303 ↗Kurz gefasst
Netzwerk-Metaanalyse in der Zeitschrift Translational Cancer Research, 2023-04. Verfasst von Huijing Li und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiotherapy, Hebei Province Hospital of Chinese Medicine, Hebei University of Chinese Medicine, Shijiazhuang, China. Die Arbeit wurde bisher 7-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Incidence of cancer-related fatigue (CRF), which can persist 5 to 10 years, is nearly 85% in cancer patients. It severely affects the quality of life and is strongly associated with poor prognosis. As clinical trial data on CRF treated with methylphenidate and ginseng, two potential medicines, has been accumulating, an updated meta-analysis was performed to evaluate and compare the efficacy and safety of the two medicines in CRF.
Methods
Randomized controlled trials that investigated methylphenidate or ginseng in the treatment of CRF were identified through a literature search. The primary outcome was CRF relief. Standardized mean difference (SMD) was used to analyze the effect.
Results
Eight studies on methylphenidate were included and the pooled SMD was 0.18 [95% confidence interval (95% CI): -0.00 to 0.35, P=0.05]. Five studies on ginseng were included and the SMD was 0.32 (95% CI: 0.17-0.46, P
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiotherapy, Hebei Province Hospital of Chinese Medicine, Hebei University of Chinese Medicine, Shijiazhuang, China.
- Key Laboratory of Integrated Chinese and Western Medicine for Gastroenterology Research (Hebei), Shijiazhuang, China.
Zitieren
APA
Li, H., Che, K., Zhi, Z., Xu, W., Huang, J., Wang, X., Liang, X., Zhao, T., Hu, J., Hou, T., Sun, S., & He, J. (2023). Efficacy and safety of methylphenidate and ginseng in cancer-related fatigue: a network meta-analysis of randomized controlled trials. Translational Cancer Research, 12(4), 732-742. https://doi.org/10.21037/tcr-22-2303
Vancouver
Li H, Che K, Zhi Z, Xu W, Huang J, Wang X, et al. Efficacy and safety of methylphenidate and ginseng in cancer-related fatigue: a network meta-analysis of randomized controlled trials. Translational Cancer Research. 2023;12(4):732-742. doi:10.21037/tcr-22-2303
BibTeX
@article{Li2023,
author = {Li, Huijing and Che, Kaimeng and Zhi, Zheng and Xu, Wenzhong and Huang, Jing and Wang, Xueqi and Liang, Xi and Zhao, Tianhe and Hu, Jingnan and Hou, Tianwen and Sun, Shijiang and He, Jianming},
title = {Efficacy and safety of methylphenidate and ginseng in cancer-related fatigue: a network meta-analysis of randomized controlled trials},
journal = {Translational Cancer Research},
year = {2023},
volume = {12},
number = {4},
pages = {732--742},
doi = {10.21037/tcr-22-2303}
}
EUVIMED